Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - ZOGENIX, INC. | zgnx-20201231xex322.htm |
EX-32.1 - EX-32.1 - ZOGENIX, INC. | zgnx-20201231xex321.htm |
EX-31.2 - EX-31.2 - ZOGENIX, INC. | zgnx-20201231xex312.htm |
EX-31.1 - EX-31.1 - ZOGENIX, INC. | zgnx-20201231xex311.htm |
EX-23.1 - EX-23.1 - ZOGENIX, INC. | zgnx-20201231xex231.htm |
EX-10.24 - EX-10.24 - ZOGENIX, INC. | zgnx-20201231exx1024.htm |
10-K - 10-K - ZOGENIX, INC. | zgnx-20201231.htm |
Exhibit 21.1
SUBSIDIARIES OF ZOGENIX, INC.
All subsidiaries are wholly-owned, directly or indirectly, by Zogenix, Inc.
Name of Subsidiary | Jurisdiction of Formation | |||||||
Modis Therapeutics, Inc. | Delaware | |||||||
Name of Non-U.S. Subsidiary | Jurisdiction of Formation | |||||||
Zogenix Europe Limited | United Kingdom | |||||||
Zogenix GmbH | Germany | |||||||
Zogenix International Limited | United Kingdom | |||||||
Zogenix K.K. | Japan | |||||||
Zogenix ROI Limited | Ireland | |||||||
Zogenix SAS | France | |||||||
Zogenix S.r.l. | Italy |